(Reuters) -Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.

Bluebird said late Friday that Ayrmid made an unsolicited offer to buy the company in a cash-and-stock transaction with an upfront cash payment of $4.50 per share and a one-time contingent value right ...

Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of ...

Investors in Blue Bird Corporation BLBD need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2025 $22.50 Call had some of the highest ...

I believe Blue Bird shares could be near rock bottom, with potential support in the low $30s after a steep 40% selloff.

For every Amazon, there are a dozen Pet.Coms, eToys and Webvans. For every Bill Gates and Steve Jobs, there are thousands of ...

We recently compiled a list of the 12 Cheap EV Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, inc.

Agrinam Acquisition Corporation (TSX: AGRI.U) ("Agrinam") and Blue Energy and Electricity, S.A. de C.V. ("Blue Energy"), a leading independent energy supplier, specializing in the provision of ...

With more than half of Ireland's birds at risk of extinction, an Irish ornithologist is utilising recordings he has made to advocate for their preservation. Seán Ronayne has approximately 12,000 ...

DUNEDIN – Bo Bichette and Addison Barger both homered as the Toronto Blue Jays scored eight unanswered runs to defeat the Houston Astros 8-3 on Monday in spring training action. Jake Meyers ...